Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly.
Por:
Biagetti B, Marques P, Ferrer R, Cardoso LM, Moreno EV, Fajardo-Montañana C, Gonzalez-Fernandez L, Pérez Pena MM, García-Centeno R, Lozano-Aida C, Novoa-Testa I, Pascual-Corrales E, Sánchón R, Guerrero-Pérez F, Rodríguez RO, Jiménez BR, Ollero García MD, Echarri AI, Simó-Servat A, Moure Rodríguez MD, Calatayud M, Villar-Taibo R, Tenorio-Jimenéz C, Novo-Rodríguez C, Molero IG, Iglesias P, Blanco C, Vidal-Ostos De Lara F, Aulinas A, Asla Roca Q, Paja M, Abellán Galiana P, Cordido F, Menéndez Torre E, Cámara R, Sarria-Estrada S, Aznar Rodríguez S, Lamas C, Alvarez-Escola C, Bernabéu I, Hanzu F, Marazuela M, Puig-Domingo M and Araujo-Castro M
Publicada:
1 feb 2026
Ahead of Print:
14 oct 2025
Resumen:
OBJECTIVE: To identify distinct clinical phenotypes in acromegaly based on growth hormone (GH) assay standardization and unsupervised machine learning. METHODS: This was a multicenter cross-sectional analysis of 416 patients diagnosed with acromegaly from 2010 onward. Patients were stratified according to baseline serum GH levels standardized to the assay-specific upper limit of normal (GHxULN) using a binary classification (GH-B: <1.0×ULN vs =1.0×ULN) and a four-tier classification (GH-4: <0.25, 0.25-0.99, 1.0-9.9, =10×ULN). Unsupervised cluster analysis included age, GHxULN, insulin-like growth factor 1 (IGF-1)xULN, tumor diameter, and T2-weighted signal intensity. RESULTS: Overall, 36% of patients had GH levels within the normal reference range for their assay (GH-B <1.0×ULN). Microadenomas (23.1%) were more frequent in older patients and associated with lower GH/IGF-1 levels. Across GH-4 categories, significant gradients were observed for age (z = -5.34, P < .001), tumor size (z = 8.01, P < .001), IGF-1 (z = 9.00, P < .001), and symptom duration (z = 4.34, P < .001). Higher GH categories were associated with greater odds of arthropathy (odds ratio 3.5, P = .015 for 1.0-9.9×ULN and odds ratio 6.58, P = .002 for =10×ULN). Cluster analysis revealed 3 phenotypes: cluster 1 (49.0%) [older age, lower GH/IGF-1, intermediate tumor size]; cluster 2 (44.4%) [intermediate age, moderate biochemical activity, smaller tumors]; cluster 3 (6.6%) [younger age, markedly elevated GH/IGF-1, large aggressive tumors]. CONCLUSION: GH standardization to assay-specific ULN reveals clinically meaningful phenotypes in acromegaly that correlate with age, tumor characteristics, and disease severity (particularly arthropathy). GHxULN complements IGF-1 by capturing tumor secretory activity, and this stratification approach may support more individualized clinical decision-making.
Filiaciones:
Biagetti B:
Endocrinology & Nutrition Department, Hospital Universitario Vall de Hebrón, Reference Networks (ERN), Barcelona, Spain
Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
Autonomous University of Barcelona, Bellaterra (Cerdanyola del Vallès), Spain
Marques P:
Pituitary Tumor Unit, Endocrinology Department, Hospital CUF Descobertas, Lisbon, Portugal
Faculdade de Medicina, Universidade Católica Portuguesa, Lisbon, Portugal
Ferrer R:
Department of Biochemistry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
Cardoso LM:
Department of Endocrinology, Diabetes and Metabolism, Coimbra Local Health Unity, Coimbra, Portugal
i3S - Institute for Research and Innovation in Health of the University of Porto, Porto, Portugal
IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
CIBIT - Coimbra Institute for Biomedical Imaging and Translational Research, Coimbra, Portugal
Moreno EV:
Endocrinology and Nutrition Department, Hospital Universitario Virgen del Rocío, Seville, Spain
Fajardo-Montañana C:
Endocrinology & Nutrition Department, Hospital Universitario La Ribera, Valencia, Spain
Gonzalez-Fernandez L:
Endocrinology & Nutrition Department, Hospital Universitario Gregorio Marañón, Madrid, Spain
Pérez Pena MM:
Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
García-Centeno R:
Endocrinology & Nutrition Department, Hospital Universitario Gregorio Marañón, Madrid, Spain
Lozano-Aida C:
Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Asturias, Spain
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain
Novoa-Testa I:
Endocrinology & Nutrition Department, Hospital Universitario A Coruña & Universidad de A Coruña, A Coruña, Spain
Pascual-Corrales E:
Endocrinology & Nutrition Department, Hospital Universitario de Toledo, Toledo, Spain
Sánchón R:
Endocrinology & Nutrition Department, Hospital Universitario de Toledo, Toledo, Spain
Guerrero-Pérez F:
Endocrinology & Nutrition Department, Hospital Universitario de Bellvitge, Cataluña L'Hospitalet de Llobregat, Barcelona, Spain
Rodríguez RO:
Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain
Jiménez BR:
Endocrinology & Nutrition Department, Hospital Universitario Virgen de la Macarena, Sevilla, Spain
Ollero García MD:
Endocrinology & Nutrition Department, Hospital Universitario Navarra, Pamplona, Spain
Echarri AI:
Endocrinology & Nutrition Department, Hospital Universitario Navarra, Pamplona, Spain
Simó-Servat A:
Endocrinology & Nutrition Department, Hospital Universitario Terrasa, Terrasa, Spain
Moure Rodríguez MD:
Endocrinology & Nutrition Department, Hospital Universitario de Cruces, Bilbao, Spain
Calatayud M:
Endocrinology & Nutrition Department, Hospital Universitario 12 de Octubre, Madrid, Spain
Villar-Taibo R:
Endocrinology & Nutrition Department, Hospital Universitario de Santiago de Compostela, Galicia, Spain
Tenorio-Jimenéz C:
Endocrinology & Nutrition Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
Novo-Rodríguez C:
Endocrinology & Nutrition Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
Molero IG:
Endocrinology & Nutrition Department, Hospital Regional Universitario de Málaga, IBIMA Plataforma BIONAND, Málaga, Spain
Iglesias P:
Endocrinology and Nutrition Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Blanco C:
Endocrinology & Nutrition Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain
Vidal-Ostos De Lara F:
Endocrinology & Nutrition Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain
Aulinas A:
Endocrinology & Nutrition Department, Hospital de la Santa Creu i Sant Pau, IR-SANT PAU, Barcelona, Spain
Asla Roca Q:
Endocrinology & Nutrition Department, Hospital de la Santa Creu i Sant Pau, IR-SANT PAU, Barcelona, Spain
Paja M:
Endocrinology & Nutrition Department, OSI Bilbao-Basurto, Hospital Universitario de Basurto, Bilbao, Spain
University of the Basque Country UPV/EHU, Bilbao, Spain
Abellán Galiana P:
Endocrinology and Nutrition Department, Hospital Universitario de Castellón, Valencia, Spain
Cordido F:
Endocrinology & Nutrition Department, Hospital Universitario A Coruña & Universidad de A Coruña, A Coruña, Spain
Menéndez Torre E:
Endocrinology & Nutrition Department, Hospital Universitario Central de Asturias, Asturias, Spain
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain
Cámara R:
Endocrinology and Nutrition Service, La Fe University Hospital, Valencia, Spain
Sarria-Estrada S:
Neuroradiology Section, Radiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
Aznar Rodríguez S:
Endocrinology & Nutrition Department, Hospital Universitario De Albacete, Albacete, Spain
Lamas C:
Endocrinology & Nutrition Department, Hospital Universitario De Albacete, Albacete, Spain
Alvarez-Escola C:
Endocrinology and Nutrition Department, Hospital Universitario La Paz, Madrid, Spain
Bernabéu I:
Endocrinology & Nutrition Department, Hospital Universitario de Santiago de Compostela, Galicia, Spain
Hanzu F:
Endocrinology & Nutrition Department, Hospital Clinic de Barcelona, Barcelona, Spain
Marazuela M:
Endocrinology & Nutrition Department, Hospital Universitario La Princesa Madrid, Madrid, Spain
:
Endocrinology & Nutrition Department, Hospital Universitario Germans Trias i Pujol, Badalona, Spain
Araujo-Castro M:
Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain
|